Mouse Anti-GPAA1 Recombinant Antibody (CBFYH-0432) (CBMAB-H1304-FY)

Ge, S., Zhang, Q., & Yang, X. (2022). GPAA1 promotes the proliferation, invasion and migration of hepatocellular carcinoma cells by binding to RNA‑binding protein SF3B4. Oncology Letters, 23(5), 1-8.

Castle, A. M., Salian, S., Bassan, H., Sofrin-Drucker, E., Cusmai, R., Herman, K. C., ... & Campeau, P. M. (2021). Expanding the Phenotypic Spectrum of GPI Anchoring Deficiency Due to Biallelic Variants in GPAA1. Neurology Genetics, 7(6).

Zhang, J. X., Wang, J. H., Sun, X. G., & Hou, T. Z. (2020). GPAA1 promotes progression of childhood acute lymphoblastic leukemia through regulating c-myc. Eur Rev Med Pharmacol Sci, 24(9), 4931-9.

Li, Y., Yang, L., Yang, J., Shi, J., Chai, P., Ge, S., ... & Jia, R. (2020). A novel variant in GPAA1, encoding a GPI transamidase complex protein, causes inherited vascular anomalies with various phenotypes. Human Genetics, 139, 1499-1511.

Su, C. T. T., Sinha, S., Eisenhaber, B., & Eisenhaber, F. (2020). Structural modelling of the lumenal domain of human GPAA1, the metallo-peptide synthetase subunit of the transamidase complex, reveals zinc-binding mode and two flaps surrounding the active site. Biology direct, 15(1), 1-17.

Zhang, X. X., Ni, B., Li, Q., Hu, L. P., Jiang, S. H., Li, R. K., ... & Zhang, Z. G. (2019). GPAA1 promotes gastric cancer progression via upregulation of GPI-anchored protein and enhancement of ERBB signalling pathway. Journal of Experimental & Clinical Cancer Research, 38(1), 1-19.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols